Tiny study checks if two drugs clash in the body

NCT ID NCT07457203

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study will test how buagafuran capsules and voriconazole tablets affect each other in 18 healthy Chinese adults over 7 days. Researchers will measure drug levels in the blood and watch for side effects. The goal is simply to gather safety and interaction data, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

buagafuran and voriconazole

What this could lead to

If successful, this study could help doctors understand how to safely combine buagafuran with voriconazole in future treatments.

What could go wrong

This is a very early, small study in healthy people, not patients. It only looks at drug levels and safety, not whether the combination works for any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Union Pharmaceutical Factory Ltd

    Beijing, Beijing Municipality, 102600, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••